Clinical Trials
3
Active:0
Completed:2
Trial Phases
2 Phases
Phase 3:1
Phase 4:1
Drug Approvals
52
CANADA:26
Drug Approvals
- Prev
- 1
- 2
- 3
- Next
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 3
1 (50.0%)Phase 4
1 (50.0%)Assessment in Work Productivity and the Relationship With Cognitive Symptoms in Patients With MDD Taking Vortioxetine
- First Posted Date
- 2015-01-07
- Last Posted Date
- 2018-01-30
- Lead Sponsor
- Lundbeck Canada Inc.
- Target Recruit Count
- 226
- Registration Number
- NCT02332954
- Locations
- 🇨🇦
CA004, Edmonton, Alberta, Canada
🇨🇦CA005, Kelowna, British Columbia, Canada
🇨🇦CA006, St. John's, Newfoundland and Labrador, Canada
Real Life Assessment of Abilify Maintena
Terminated
- Conditions
- Schizophrenia
- First Posted Date
- 2014-05-06
- Last Posted Date
- 2017-03-10
- Lead Sponsor
- Lundbeck Canada Inc.
- Target Recruit Count
- 200
- Registration Number
- NCT02131415
- Locations
- 🇨🇦
CA012, Calgary, Alberta, Canada
🇨🇦CA008, Penticton, British Columbia, Canada
🇨🇦CA017, Vancouver, British Columbia, Canada
Bendamustine Hydrochloride (HCl) in Indolent Non-Hodgkin's Lymphoma That Has Progressed During or Following Treatment With a Rituximab Regimen or Previously Untreated Chronic Lymphocytic Leukemia
Phase 3
Completed
- Conditions
- Indolent Non-Hodgkin's LymphomaChronic Lymphocytic Leukemia
- Interventions
- First Posted Date
- 2011-12-26
- Last Posted Date
- 2017-08-14
- Lead Sponsor
- Lundbeck Canada Inc.
- Target Recruit Count
- 90
- Registration Number
- NCT01500083
- Locations
- 🇨🇦
CA015, Calgary, Alberta, Canada
🇨🇦CA014, Edmonton, Alberta, Canada
🇨🇦CA016, Kelowna, British Columbia, Canada
News
No news found